Skip to main content
INTCO MEDICAL TECHNOLOGY CO., LTD. logo

INTCO MEDICAL TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 300677 ISIN · CNE100003456 LEI · 549300U6H4L6SSU31U28 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,901 across all filing types
Latest filing 2026-06-03 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300677

About INTCO MEDICAL TECHNOLOGY CO., LTD.

https://www.intcomedical.com.cn

INTCO Medical Technology Co., Ltd. is a high-tech manufacturer specializing in the research, development, production, and marketing of medical consumables and durable medical equipment. The company's primary product portfolio includes a wide range of disposable medical gloves, such as nitrile, vinyl, and latex varieties, which serve as critical protective gear in healthcare and industrial settings. Beyond consumables, the firm produces durable medical equipment including manual and electric wheelchairs, hospital beds, and patient mobility aids. It also offers physical therapy products like cold and hot packs and various medical electrodes. With a focus on large-scale production and advanced manufacturing technology, the company serves a global clientele across healthcare, laboratory, and food service sectors. Its operations emphasize quality control and compliance with international standards to ensure product safety and reliability.

Recent filings

Filing Released Lang Actions
2025年度权益分派实施公告
Notice of Dividend Amount Classification · 97% confidence The document is an announcement by the company regarding the implementation of its 2025 annual cash dividend distribution, specifying per‐share dividend amounts, record date, ex‐dividend date, payment procedures, and related details. This clearly matches a Notice of Dividend Amount filing rather than a full financial report or other corporate action.
2026-06-03 Chinese
关于为子公司提供担保事项的进展公告
Regulatory Filings Classification · 65% confidence The document is a corporate announcement (“公告”) detailing the progress of guarantees provided by the listed company to its subsidiaries, including guarantee amounts, contracts, and counterparty information. It is not a financial report (no audited/full financial statements), not a capital raising notice per se, nor an interim/annual report, nor a management change, M&A, or dividend notice. It is a regulatory/compliance announcement falling under miscellaneous filings. Therefore it best fits the Regulatory Filings category.
2026-05-29 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 75% confidence The document is an announcement by the company disclosing that its controlling shareholder (Liu Fangyi) has released (unpledged) a portion of his pledged shares. It contains no actual financial statements or indications of a share issuance, buyback, or earnings release. It is not a management change notice or voting result, nor is it a major shareholding change in terms of ownership percentage. It is a mandated regulatory announcement of the shareholder’s pledge/unpledge status. Thus it falls under the general Regulatory Filings category (RNS).
2026-05-28 Chinese
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings Classification · 30% confidence The document is an official announcement of the controlling shareholder’s share pledge and release of pledge. It is not a meeting presentation, earnings release, proxy statement, or financial report. It does not describe a share issuance by the company nor a board change or dividend, nor is it an insider buy/sell trade filing. There is no applicable specialized category for collateral pledges by a major shareholder, so this falls into the general regulatory announcement catch-all.
2026-05-27 Chinese
关于公司及子公司提供担保事项的进展公告
Regulatory Filings Classification · 90% confidence The document is a public announcement by a listed company regarding the progress of guarantee arrangements provided by the company and its subsidiaries. It is neither an earnings release, financial report, nor board change; rather it is a routine regulatory disclosure of credit guarantees under listing rules. It does not contain actual financial statements to qualify as an Interim or Annual Report, nor is it a financing announcement in the sense of raising new capital. Therefore, it falls under the catch-all “Regulatory Filings” category for miscellaneous compliance disclosures.
2026-05-21 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is a formal announcement detailing the agenda items at the 2025 annual shareholders’ meeting of Yingke Medical Technology Co., Ltd., including the voting results for each proposal, percentages of votes for, against, and abstentions. This precisely matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (DVA), which covers official results from shareholder votes at general meetings.
2026-05-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.